- Latest Stories
- Commentary and Analysis
1:42PM ET 4/08/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
11:02AM ET 4/07/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
9:03AM ET 2/14/2022 MT Newswires ...
10:46AM ET 7/07/2021 MT NewswiresGeert R Kersten, Director and CEO, purchased 25,000 shares of Cel-Sci (CVM) on Jul 06, 2021, for $200,000. After the Form 4 filing with the SEC, Kersten...
3:11PM ET 6/30/2021 MT NewswiresCel-Sci (CVM) said Wednesday that it will hold an investor call on Thursday at the end of its annual shareholder meeting to discuss phase 3 head and neck...
10:27AM ET 6/28/2021 MT NewswiresCel-Sci (CVM) said Monday that its Multikine immunotherapy yielded significant overall survival benefit in patients with advanced and primary squamous cell...
12:33PM ET 6/11/2021 MT NewswiresCel-Sci (CVM) said Friday it closed its offering of 1.4 million common shares priced at $22.62 each for gross proceeds of about $31.7 million. The company...
9:20AM ET 6/09/2021 MT NewswiresHealth care stocks were advancing premarket Wednesday. The Health Care SPDR (XLV) was 0.27% higher and the iShares NASDAQ Biotechnology Index (IBB) was...
9:12AM ET 6/09/2021 MT NewswiresUS stocks were set for narrow gains Wednesday as traders remained on the sidelines awaiting fresh catalysts from a reading on US inflation later in the...
4:00AM ET 6/09/2021 MT NewswiresCel-Sci (CVM) on Tuesday increased its previously announced bought-deal offering to 1.4 million common shares from 1 million shares due to demand. The...